Zoonosis is an infectious disease that has jumped from non-human animals to humans. To date, more than 200 known types of zoonoses have been identified, and 60% of emerging infectious diseases are zoonotic. It is estimated that zoonoses are responsible for 2.5 billion cases of human illness and 2.7 million human deaths worldwide each year, and 50-60% of the global population (5–6 billion) are projected to be at risk of zoonotic infections. Emerging and re-emerging zoonoses, such as monkeypox, Ebola, SARS, MERS, Zika, Rickettsia, and Mycobacteria, pose an immense and growing threat to global health, economy, and safety. As of September 26, 2022, there have been more than 600 million cases confirmed with COVID-19, and 6,514,397 deaths occurred due to this highly communicable disease. Identification of the immunological aspects of emerging and re-emerging zoonoses may facilitate the diagnosis, vaccine, and therapeutics development of emerging and re-emerging zoonoses.
The goal of this Research Topic is to improve the understanding of the immunological aspects of emerging and re-emerging viral zoonoses in this changing world. All submissions pertaining to the latest knowledge on epidemiology, immunological basis, immuno-diagnosis, vaccines, and therapeutics of emerging and re-emerging viral zoonoses will be given full consideration for publication.
This Research Topic aims to publish Original Research and Review articles depicting the immunological aspects of emerging and re-emerging viral zoonoses in both clinical and basic studies, to support the containment and elimination of viral zoonoses. Subtopics around emerging and re-emerging viral zoonoses include, but are not limited to, the following:
(1) Epidemiology of emerging and re-emerging viral zoonoses
(2) Innate and adaptive immunity against emerging and re-emerging viral zoonoses
(3) Immune memory
(4) Neuro-immunology
(5) Immuno-diagnosis
(6) Vaccine development
(7) Immune therapeutics
Zoonosis is an infectious disease that has jumped from non-human animals to humans. To date, more than 200 known types of zoonoses have been identified, and 60% of emerging infectious diseases are zoonotic. It is estimated that zoonoses are responsible for 2.5 billion cases of human illness and 2.7 million human deaths worldwide each year, and 50-60% of the global population (5–6 billion) are projected to be at risk of zoonotic infections. Emerging and re-emerging zoonoses, such as monkeypox, Ebola, SARS, MERS, Zika, Rickettsia, and Mycobacteria, pose an immense and growing threat to global health, economy, and safety. As of September 26, 2022, there have been more than 600 million cases confirmed with COVID-19, and 6,514,397 deaths occurred due to this highly communicable disease. Identification of the immunological aspects of emerging and re-emerging zoonoses may facilitate the diagnosis, vaccine, and therapeutics development of emerging and re-emerging zoonoses.
The goal of this Research Topic is to improve the understanding of the immunological aspects of emerging and re-emerging viral zoonoses in this changing world. All submissions pertaining to the latest knowledge on epidemiology, immunological basis, immuno-diagnosis, vaccines, and therapeutics of emerging and re-emerging viral zoonoses will be given full consideration for publication.
This Research Topic aims to publish Original Research and Review articles depicting the immunological aspects of emerging and re-emerging viral zoonoses in both clinical and basic studies, to support the containment and elimination of viral zoonoses. Subtopics around emerging and re-emerging viral zoonoses include, but are not limited to, the following:
(1) Epidemiology of emerging and re-emerging viral zoonoses
(2) Innate and adaptive immunity against emerging and re-emerging viral zoonoses
(3) Immune memory
(4) Neuro-immunology
(5) Immuno-diagnosis
(6) Vaccine development
(7) Immune therapeutics
